Abstract
Mounting evidence suggests that gut microbiota can play an important role in pathophysiology of depression, but its specific molecular mechanisms are still unclear. This study was conducted to explore the associations between changes in neurotransmitters and short-chain fatty acids (SCFAs) and altered gut microbiota in depressed mice. Here, the chronic restraint stress (CRS) model of depression was built. The classical behavioral tests were conducted to assess the depressive-like behaviors of mice. The 16S rRNA gene sequence extracted from fecal samples was used to assess the gut microbial composition. Liquid and gas chromatography mass spectroscopy were used to identify neurotransmitters in hypothalamus and SCFAs in fecal samples, respectively. Finally, 29 differential bacteria taxa between depressed mice and control mice were identified, and the most differentially abundant bacteria taxa were genus Allobaculum and family Ruminococcaceae between the two groups. The acetic acid, propionic acid, pentanoic acid, norepinephrine, 5-HIAA and 5-HT were significantly decreased in depressed mice compared to control mice. Genus Allobaculum was found to be significantly positively correlated with acetic acid and 5-HT. Taken together, these results provided novel microbial and metabolic frameworks for understanding the role of microbiota-gut-brain axis in depression, and suggested new insights to pave the way for novel therapeutic methods.
Similar content being viewed by others
Introduction
Depression is a debilitating disease that involves a loss of interest in activities, a low mood and a persistent feeling of sadness. Nowadays, depression has become the leading cause of disability globally and affects nearly 6% of the adult population worldwide each year1. It is the result of complex gene-environment interactions. The genetic contribution to this disease is expected to be nearly 35%, and environmental factors (such as sexual and stress) are also strongly related with the development of depression2,3. Many theories have been developed to explain the pathogenesis of depression, such neurotransmission deficiency and endocrine-immune system dysfunction4,5. But none of these theories has been universally accepted. Thus, it is urgently needed to find a novel pathophysiologic mechanisms underlying depression.
Currently, there is growing evidence indicating that gut microbiota can play an important role in the pathophysiology of depression6,7,8. Zheng et al. reported that gut microbiota might be involved in the onset of depressive-like behaviors by regulating gut-brain axis glycerophospholipid metabolism6. Another study showed that gut microbiota could increase the depression-like behavior and inflammatory processes in the ventral hippocampus of stress vulnerable individuals7. Our studies in humans have observed differences in gut microbiota composition between patients with depression and healthy controls9,10,11. Other studies also found the altered gut microbiota composition in depressed patients12,13. These studies have successfully identified variations in some bacteria taxa, such as phyla Bacteroidetes, phyla Actinobacteria and genera Alistipes. Meanwhile, we have pioneered the fecal transplantation model of depression by transferring the feces from patients with depression to germ-free mice to induce depressive-like behavior9. These preliminary results suggested the close relationship between depression and disordered gut microbiota, but could not show a causal relationship between the differential gut microbial compositions and depression. Nowadays, there has been limited direct evidence linking depression and gut microbiota, and no causal connection has yet been proven.
Emerging evidence also indicates that gut microbiota can affect the host brain function through the microbiota-gut-brain (MGB) axis14,15. But the specific signaling mechanisms in the MGB axis are still unclear. Gut microbiota can produce many substances, such as short-chain fatty acids (SCFAs), neurotransmitters and gut hormones. Neurotransmitters, such as norepinephrine, dopamine and 5-hydroxytryptamine (5-HT), can be synthesized by gut microbiota16. In some cases, gut microbiota can regulate the 5-HT signaling by mediating the tryptophan metabolism17. SCFAs, such as acetic acid, propionic acid, and butyric acid, can enter the circulatory system; then it is possible that gut microbiota may signal to host brain via this route18. Therefore, in order to explore the possible mechanisms involved in the crosstalk between brain function and gut microbiota, we conducted this study to investigate the associations between altered gut microbiota and changes of neurotransmitters in hypothalamus and SCFAs in fecal samples in depressed mice.
Chronic stress plays a critical role in the development of depression. McEwen et al. reported that repeat stress, such as 21 days of CRS, could result in structural and functional changes in brain regions19. Some brain regions, such as prefrontal cortex and hypothalamus, are associated with cognition, emotion regulation and learning20. Currently, chronic stress, including CRS and chronic mild stress (CMS), is the most widely used animal model of depression21. But, two drawbacks limit the widespread use of CMS model: difficult to replicate across laboratories and high operation costs along with the long period22. In contrast, CRS has been widely used in stress-induced depression model because of its low operation costs and readily accessible stress operation procedure23. Therefore, we used CRS-induced depression model in this study.
Methods and materials
Male adult C57BL/6 mice
Male adult C57BL/6 mice (8–16 weeks of age; about 20 g) were purchased from the Laboratory Animal Center of Chongqing Medical University and used to build CRS model of depression. The mice were individually housed under standard conditions: 12 h light/dark cycle; 22 ± 1 °C temperature; 52 ± 2% humidity; free access to food and water. This study was approved by the Ethics Committee of Chongqing Medical University (Approval No. 20170301). The whole procedures were conducted according to the National Institutes of Health Guidelines for Animal Research (Guide for the Care and Use of Laboratory Animals, NIH Publication No.8023, revised 1996). When the experiment began, the mice were randomly assigned into two groups using a computer generated randomization table. In one group, mice were exposed to CRS by placing them in 50ml-plastic tubes. There were a few holes on the tubes to keep air flow for 4 h per day. During the restraint time, the mice were under water and food deprivation. In another group, mice were free access to food and water without restraint. The total process continued 28 consecutive days. To ensure that the possible differences between the two groups could be detected, the number of mice was set to 20 in each group. Meanwhile, ten mice in each group were randomly selected to measure gut microbiota composition, neurotransmitters and SCFAs. In many previous studies, the number of mice was set to eight in each group to assess the differences on metabolite, protein or gut microbiota composition between the two groups24,25. Thus, the sample sizes in this study were likely to result in sufficient power, even if power analysis was not performed.
Behaviors testing
Open field test (OFT): each mouse was individually put at the center of box (45 × 45 × 45 cm). To remove olfactory cues, the 70% alcohol and water were used to clean the box after each test. The mice were allowed to explore the box for 6 min. The total distance, center distance and center time in the last 5 min were recorded; Forced swim test (FST): the mice were assigned to do a pre-test (15 min) swim one day before FST. Each mouse was individually put in a Plexigals cylinder (15 cm diameter and 30 cm height) filled with 18 cm of water (24 ± 1 °C). The water was replaced after each test. The immobility time was recorded in the 5 min period; Sucrose preference test (SPT): the mice were trained to adapt to a 1% sucrose solution 72 h before SPT: two bottles with 1% sucrose solution were placed, and 24 h later, the liquid in one bottle was replaced with water for 24 h. In the last 24 h period, the mice were under water and food deprivation. After adaption, the mice were free access to two bottles: one containing water and the other one containing 1% sucrose solution. The positions of the two bottles (left or right sides) were randomly changed. The liquid consumptions in 24 h were recorded, and the sucrose preference was defined as [100% × sucrose consumption/(sucrose consumption + water consumption). The investigator was blinded to the group allocation and outcomes assessment.
Neurotransmitter identification
First, we added 200 μl ultrapure water (1% formic acid, FA) into the hypothalamus tissue, and the mixture were homogenized for three times in a disposable glass tube. Then, 800 μl (1% FA) pre-cooling pure acetonitrile was added into the mixture for vortex mixing. Later, we put the homogenate in the ice bath (−20 °C) for 1 h incubation, and the obtained protein deposition were induced in an ice bath for 20 min by ultrasound. Fourthly, the samples were centrifuged at 14,000 × g × 20 min under 4 °C, and the obtained supernatant was transferred into a glass vial to conduct vacuum-drying. When conducting mass spectrometry detection, 100 μl (1% FA) ACN/water (1:1, v/v) were added into the samples to dissolve. Then, the mixture was centrifuged at 14,000 × g × 20 min under 4 °C. Finally, the obtained supernatant was used to identify neurotransmitters using LC-MS system. The detailed information of LC-MS procedure was displayed in Supplementary file 1.
SCFAs identification
First, sample preparation was conducted: (1) added 1 ml NaOH solution (5 mmol/l) into 50 mg fecal samples (pre-cooled under 4 °C); (2) the mixture was homogenized for 3 min (sample tray was pre-cooled at −20 degrees), and then ultrasonically extracted for 7 min in an ice bath; (3) after centrifugation (12,000 r.p.m. × 10 min, 4 °C), transferred 500 μl supernatant into an injection vial and then added 300 μl pure water. Then, sample derivation was conducted: (1) added 500 μl propanol/pyridine (3:2, v/v) and 100 μl propyl chloroformate into the injection vial, conducted vortex for 10 s and then sonicate for 1 min; (2) added 300 μl n-hexane into the injection vial and conducted vortex (2000 r.m.p. × 60 s); (3) after centrifugation (12,000 r.p.m. × 5 min, 4 °C), transferred 250 μl obtained n-hexane layer into a new injection vial; (4) continually added 200 μl n-hexane into the original injection vial and conducted vortex (2000 r.m.p. × 60 s); (5) after centrifugation (12,000 r.p.m. × 5 min, 4 °C), transferred 200 μl n-hexane layer into the new injection vial; (6) added 10 mg anhydrous sodium sulfate into the obtained 450 μl n-hexane layer and conducted vortex for 10 s, and then analyzed using GC-MS system. Later, standards derivation was conducted: (1) added 300 μl mixed standards solution and 500 μl NaOH solution (0.005 mol/l) into an injection vial; (2) added 500 μl propanol/pyridine (3:2, v/v) and 100 μl propyl chloroformate into the injection vial, conducted vortex for 10 s and then sonicate for 1 min; (3) added 300 μl n-hexane into the injection vial and conducted vortex (2000 rmp × 60 s); (4) after centrifugation (12,000 r.p.m. × 5 min, 4 °C), transferred 250 μl obtained n-hexane layer into a new injection vial; (5) continually added 200 μl n-hexane into the original injection vial and conducted vortex (2000 r.m.p. × 60 s); (6) after centrifugation (12,000 r.p.m. × 5 min, 4 °C), transferred 200 μl n-hexane layer into the new injection vial; (7) added 10 mg anhydrous sodium sulfate into the obtained 450 μl n-hexane layer and conducted vortex for 10 s, and then analyzed using GC-MS system. The detailed information of GC-MS procedure was displayed in Supplementary file 1.
16S rRNA gene sequencing
Fecal samples were collected from the mice, and then immediately frozen and stored under −80 °C before analysis. We used the mortar and pestle to pulverize the fecal samples, and used the standard power soil kit protocol to extract the bacterial genomic DNA. Briefly, the fecal samples were thawed on the ice. Then, we added the MoBio lysis buffer into the fecal samples and conducted vortex mixing. The obtained fecal suspensions were centrifuged. Finally, we put the obtained supernatant into the MoBio Garnet bead tubes containing MoBio buffer. We used the Roche 454 sequencing system to extract the V3-V5 regions of 16s rRNA gene sequences from the fecal samples, and the obtained gene sequences were PCR-amplified with barcoded universal primers.
We used Mothur (Version 1.31.2, http://www.mothur.org/) to quality-filter the obtained raw gene sequences to collect unique reads. Sequences with <200 bp or >1000 bp, as well as sequences with any barcode mismatches, ambiguous bases, homopolymer runs exceeding six bases and primer mismatches were excluded. The remained sequences were assigned to operational taxonomic units (OTUs) with >=97% pairwise sequence identity. The Ribosomal Database Project (RDP) reference database was used to taxonomically classify the obtained OTUs.
Statistical analysis
The independent samples t-test (if the data fit the normal distribution), nonparametric Mann–Whitney U test (if the data do not fit the normal distribution), pearson correlation analysis or spearman correlation analysis was conducted when appropriate. The variances between the two groups were calculated using Levene’s test; if the variances are not similar between the two groups, the adjusted p-value was used. Meanwhile, we constructed the summaries of the taxonomic distributions of OTUs to calculate the relative abundances of gut microbiota at different levels. Four different parameters (shannon, simpson, phylogenetic diversity and chao) were used to assess the alpha diversity. Distance matrices (beta diversity) between samples were assessed using principal coordinate analysis (PCoA). Random Forest algorithm was conducted to find the key discriminatory OTUs. The linear discriminant-analysis effect size (LEfSe) was further used to identify the dominant bacteria taxa in both control mice and depressed mice. P-value <0.05 was considered significant. The method of Benjamini and Hochberg False Discovery was used to perform multiple testing corrections.
Results
Mice exposed to CRS showed depressive-like and anxiety-like behaviors
The results of OFT (n = 20, each group) showed that there was no significant difference in total distance between control mice and depressed mice (p = 0.5541, Fig. 1A). In contrast, there was significant difference in center time (p = 0.0029, Fig. 1B) and center distance (p = 0.0003, Fig. 1C), suggesting the anxiety-like behavior in depressed mice. In the FST (n = 20, each group), immobility time was widely used as an index of depression-like behavior in the literature. Here, we found that the depressed mice had significantly increased immobility time compared to control mice (p = 0.0002, Fig. 1D). Meanwhile, the SPT (n = 20, each group) was used to assess anhedonia, which was also an index of depressive-like behavior. In this study, no significance was observed in sucrose preference prior to the CRS procedure. But, the sucrose preference was found to be significantly decreased in depressed mice compared to control mice at the end of the CRS procedure (p = 0.0074, Fig. 1E). In addition, no significant difference in body weight was found at baseline, but the body weight was significantly higher in control mice than in depressed mice at last (p = 0.0022, Fig. 1F). These results showed that the mice exposed to CRS showed depressive-like and anxiety-like behaviors.
A No significant difference was found in total distance between the two groups in OFT; (B, C) the depressed mice had significantly decreased center time (B) and center distance (C) in OFT; (D) the depressed mice had significantly increased immobility time in FST; (D) the sucrose preference was significantly decreased in depressed mice in SPT. Twenty mice were in each group, and the error bars represent standard deviation.
Disordered gut microbiota between control mice and depressed mice
The results of these four parameters showed that there was no significant difference in alpha diversity between control mice and depressed mice (n = 10/10, random samples) (shannon, p = 0.6394; simpson, p = 0.3468; phylogenetic diversity, p = 0.7862; chao, p = 0.6521). However, the results of PCoA showed the significant difference in the gut microbial community compositions between control mice and depressed mice (Fig. 2A). Further analysis found that phyla Verrucomicrobia (Fig. 2B), eight differential bacteria taxa on family level (Fig. 2C), and 13 differential bacteria taxa on genus level (Fig. 2D) were significantly changed in depressed mice. To find out the key discriminatory OTUs, Random Forest algorithm was used here. A total of 62 differential OTUs between control mice and depressed mice were identified (Fig. 2E). Of these differential OTUs, a total of 27 OTUs and 35 OTUs were overrepresented in depressed mice and control mice, respectively. The differential bacteria taxa on other levels between the two groups were displayed in Supplementary Fig. S1.
A PCoA showed an obvious difference in gut microbiotic composition between the two groups; (B) phyla Verrucomicrobia was significantly changed; (C) eight differential bacteria taxa on family level was identified; (D) 13 differential bacteria taxa on genus level were identified; (E) 62 OTUs key discriminatory OTUs whose relative abundance reliably distinguished control mice and depressed mice were identified. Ten mice were in each group.
To find out the dominant bacteria taxa in different groups, LEfSe was used in this study. It was a new method to identify the metagenomic biomarker by way of class comparison. In total, 29 bacteria taxa with statistically significant and biologically consistent differences were found here (Fig. 3). These bacteria taxa were the key phylotypes responsible for the different gut microbiota between control mice and depressed mice. The 23 bacteria taxa and 6 bacteria taxa were most abundant in control mice and depressed mice, respectively. The most differentially abundant bacteria taxa in control mice and depressed mice belonged to genus Allobaculum and family Ruminococcaceae, respectively.
Phylogenetic investigation of communities by reconstruction of unobserved states (PICRSt) was a common approach to conduct functional prediction of 16S data using a database of reference genomes and marker gene data. In this study, we used this method to conduct the functional prediction of gut microbiota. Finally, we found that the Lipid transport and metabolism of gut microbiota was significantly affected in depressed mice (p = 0.0142); more specifically, Fatty acid degradation (p = 0.0033), Glycerophospholipid metabolism (p = 0.0226), Biosynthesis of unsaturated fatty acids (p = 0.04185), Synthesis and degradation of ketone bodies (p = 0.02624), and Glycerolipid metabolism (p = 0.03558) were significantly affected.
Differentially expressed SCFAs levels in depressed mice
SCFAs, as a major class of key bacterial metabolites, were very important for human health. In this study, seven major SCFAs (acetic acid, propionic acid, butyric acid, pentanoic acid, hexanoic acid, isobutyric acid and isovaleric acid) were measured in fecal sample of control mice and depressed (n = 10/10, random samples). But at last, only four major SCFAs (acetic acid, propionic acid, butyric acid, pentanoic acid) were successfully identified. The results showed that the levels of acetic acid (p = 0.0158), propionic acid (p = 0.0011) and pentanoic acid (p = 0.0161) were found to be significantly decreased in depressed mice compared to control mice (Fig. 4A); the level of butyric acid was not significantly different between the two groups (p = 0.0996) (Fig. 4A).
A four kinds of SCFAs were detected, and acetic acid, propionic acid and pentanoic acid were found to be significantly decreased in depressed mice; (B) 11 kinds of neurotransmitters were detected, and norepinephrine, 5-HIAA and 5-HT were found to be significantly decreased in depressed mice. Ten mice were in each group, the error bars represent standard deviation, and two asterisks represents p-value < 0.01 and one asterisk represents p-value < 0.05.
Differentially expressed neurotransmitter levels in depressed mice
The perturbations in central and peripheral neurotransmitters were closely related with the pathogenesis of depression. In this study, ten kinds of neurotransmitters [r-Amino-butyric acid, dopamine, norepinephrine, 5-hydroxyindoleacetic acid (5-HIAA), 5-hydroxytryptamine (5HT), acetylcholine, histamine, tyramine, normetanephrine, glutamate and glutamine] were identified in control mice and depressed mice (n = 10/10, random samples). We obtained their relative concentration from the mass peak area of the sample analyte. The results showed that three kinds of neurotransmitters were significantly changed between the two groups. The levels of norepinephrine (P = 0.0081), 5-HIAA (P = 0.0133) and 5-HT (P = 0.0300) were found to be significantly decreased in depressed mice compared to control mice (Fig. 4B).
Correlations between the differential SCFAs, neurotransmitters and bacteria taxa
In this study, we found that (Fig. 5): (i) propionic acid (r = 0.5636, p = 0.0097) and entanoic acid (r = 0.7157, p = 0.0004) were significantly positively correlated with acetic acid; (ii) there was significantly positive correlation between pentanoic acid and propionic acid (r = 0.6319, p = 0.0028); (iii) 5-HIAA (r = 0.4487, p = 0.0472) and 5-HT (r = 0.4713, p = 0.0359) were significantly positively correlated with norepinephrine; (iv) acetic acid (r = 0.6725, p = 0.0012) and pentanoic acid (r = 0.5485, p = 0.0123) were significantly positively correlated with 5-HT.
The top left corner was the heatmap of correlations between differential SCFAs and neurotransmitters. The bottom right corner was the network map of correlations between the differential SCFAs, neurotransmitters and bacteria taxa. The scatter plots were used to intuitively display the relationships between differential SCFAs and neurotransmitters.
Meanwhile, we found that (Fig. 5): (i) there were significantly positive correlations between norepinephrine and two differential bacteria taxa: family Spirochaetaceae (r = 0.5490, p = 0.0122) and genus revotellaceae_NK3B31_group (r = 0.5110, p = 0.0212), and significantly negative correlation between norepinephrine and genus Enterorhabdus (r = −0.4631, p = 0.0396); (ii) 5-HIAA was significantly positively and negatively, respectively, correlated with class Alphaproteobacteria (r = 0.5141, p = 0.0204) and genus norank_f_Eggerthellaceae (r = −0.4600, p = 0.0413); (iii) a significantly positive correlation was found between genus Akkermansia and 5-HT (r = 0.5580, p = 0.0105); (iv) there were significantly positive correlations between acetic acid and five differential bacteria taxa: class Alphaproteobacteria (r = 0.5371, p = 0.0145), family Streptococcaceae (r = 0.5132, p = 0.0207), genus Staphylococcus (r = 0.4911, p = 0.0278), family Staphylococcaceae (r = 0.4892, p = 0.0287) and genus Akkermansia (r = 0.4450, p = 0.0495); and (v) both genus Allobaculum (r = 0.5991, p = 0.0052) and family Spirochaetaceae (r = 0.5490, p = 0.0122) were significantly positively correlated with propionic acid. Meanwhile, we did correlation analysis between all detected SCFAs, all detected neurotransmitters and differential bacteria taxa; the results were displayed in Supplementary Fig. S2.
Discussion
Previous studies have been reported that chronic stress could result in the disturbance of gut microbiota and host metabolism, which might contribute to the development of depression26,27. Here, we found that the gut microbiota, SCFAs in fecal sample and neurotransmitters in hypothalamus were significantly changed in depressed mice compared to control mice. There were 23 bacteria taxa and 6 bacteria taxa significantly decreased and increased, respectively, in depressed mice. Three major SCFAs (acetic acid, propionic acid, and pentanoic acid) and three kinds of neurotransmitters (norepinephrine, 5-HIAA and 5-HT) were found to be significantly decreased in depressed mice compared to control mice. Meanwhile, the significantly correlations between differential bacteria taxa, SCFAs and neurotransmitters were found in this study. Our results indicated that gut microbiota might play an important role in the pathogenesis of depression by regulating the levels of SCFAs in fecal sample and neurotransmitters in hypothalamus.
Although many meaningful work have been done to expand our knowledge on the relationship between host and their gut microbiota, the underpinnings of MGB crosstalk is still unclear. As the key bacterial metabolites produced in the colon by gut microbiota, SCFAs are considered to have a critical role in neuro-immunoendocrine regulation. Meanwhile, it can directly regulate the size and function of the colonic Treg pool to remain colonic homeostasis and health28. The major products from microbial fermentative activity in the intestinal tract are SCFAs, in particular, acetic acid, butyric acid, and propionic acid29. In this study, we found that there were significantly positive correlations between some bacteria taxa with decreased relative abundances and two major SCFAs with decreased levels (acetic acid and propionic acid) in depressed mice. Previous studies also reported that the levels of SCFAs were decreased in naturally occurring depressive model of macaques and depressed patients30,31. Thus, considering the anti-inflammatory property of SCFAs, these differential bacteria taxa might be closely related to the development of depression by playing a role in the inflammation process.
Much evidence suggests that hypothalamic-pituitary-adrenal (HPA) axis is closely related with the pathophysiology of depression32. The dysregulation of HPA axis is found to be a common feature in patients with depression33. In this study, we found the significantly decreased levels of norepinephrine, 5-HIAA and 5-HT in the hypothalamus of depressed mice. Both 5-HT and norepinephrine are monoamine neurotransmitters that are closely associated with depression and widely accepted as target by most of antidepressants. Previous studies reported that gut microbiota could synthesize and release many neurotransmitters, such as norepinephrine and 5-HT34,35. Here, we found that some differential bacteria taxa were significantly related with 5-HT and norepinephrine in depressed mice. These results further demonstrated that besides regulating inflammatory response, gut microbiota could affect host brain function through the regulation of HPA axis.
Genus Akkermansia is one kind of probiotics in the intestinal tract. Bárcena et al. reported that transplantation with Akkermansia muciniphila was sufficient to exert beneficial effects for the healthspan and lifespan of mice36. In this study, we found the significantly decreased abundance of genus Akkermansia in depressed mice, and the significantly positive correlation between genus Akkermansia and 5-HT in hypothalamus. Some studies reported that more than 90% 5-HT might be compartmentalized in the gut37,38. Meanwhile, we also found the significantly positive correlation between genus Akkermansia and acetic acid. Interesting, as the most abundant SCFA, acetic acid can be produced from pyruvic acid via acetyl-CoA or Wood–Ljungdahl pathway by most enteric bacteria, such as genus Akkermansia39. These results indicated that genus Akkermansia might be a potential novel target for treating depression.
In many ways, SCFAs represent the signature hormones of gut microbiota. They may act as a bridge between gut microbiota and many functions assigned to them through classical endocrine signaling. For example, SCFAs can modulate the enteroendocrine 5-HT secretion40, an important neurotransmitter at multiple levels of MGB axis. Consistent with these findings, we found the significantly positive correlations between 5-HT in hypothalamus and two major SCFAs in fecal sample (acetic acid and pentanoic acid). As the most abundant SCFA in peripheral circulation, acetic acid can cross blood-brain barrier, and reduce appetite by activating the hypothalamic neurons driving satiety41. The interaction between host brain functions and gut microbiota is a complex relationship. Our findings demonstrated that SCFAs could be the agent of gut microbiota in affecting host brain functions.
In conclusion, we found that chronic stress could result in the gut microbiota dysbiosis: 29 differential bacteria taxa between depressed mice and control mice were identified. We also found that three major SCFAs in fecal sample and three kinds of neurotransmitters in hypothalamus were significantly decreased in depressed mice compared to control mice. Meanwhile, some significant correlations between differential bacteria taxa, SCFAs and neurotransmitters were identified. Our findings might suggest a possible pathway for depression: chronic stress disordered the gut microbiota, and the gut microbiota dysbiosis resulted in the changes of neurotransmitters in hypothalamus by regulating the levels of SCFAs in intestinal tract.
References
Bromet, E. et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 9, 90 (2011).
Flint, J. & Kendler, K. S. The genetics of major depression. Neuron 81, 484–503 (2014).
Li, M., D’Arcy, C. & Meng, X. Maltreatment in childhood substantially increases the risk of adult depression and anxiety in prospective cohort studies: systematic review, meta-analysis, and proportional attributable fractions. Psychol. Med. 46, 717–730 (2016).
Luscher, B., Shen, Q. & Sahir, N. The GABAergic deficit hypothesis of major depressive disorder. Mol. Psychiatry 16, 383–406 (2011).
Dantzer, R., O’Connor, J. C., Freund, G. G., Johnson, R. W. & Kelley, K. W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9, 46–56 (2008).
Zheng, P. et al. The gut microbiome modulates gut-brain axis glycerophospholipid metabolism in a region-specific manner in a nonhuman primate model of depression. Mol. Psychiatry https://doi.org/10.1038/s41380-020-0744-2. (2020).
Pearson-Leary, J. et al. The gut microbiome regulates the increases in depressive-type behaviors and in inflammatory processes in the ventral hippocampus of stress vulnerable rats. Mol. Psychiatry 25, 1068–1079 (2020).
Li, B. et al. Metabolite identification in fecal microbiota transplantation mouse livers and combined proteomics with chronic unpredictive mild stress mouse livers. Transl. Psychiatry 8, 34 (2018).
Zheng, P. et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host’s metabolism. Mol. Psychiatry 21, 786–796 (2016).
Chen, J. J. et al. Age-specific differential changes on gut microbiota composition in patients with major depressive disorder. Aging 12, 2764–2776 (2020).
Chen, J. J. et al. Sex differences in gut microbiota in patients with major depressive disorder. Neuropsychiatr. Dis. Treat. 14, 647–655 (2018).
Jiang, H. et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav. Immun. 48, 186–194 (2015).
Naseribafrouei, A. et al. Correlation between the human fecal microbiota and depression. Neurogastroenterol. Motil. 26, 1155–1162 (2014).
Cryan, J. F. & Dinan, T. G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. Neurosci. 13, 701–712 (2012).
Heijtz, R. D. et al. Normal gut microbiota modulates brain development and behavior. Proc. Natl Acad. Sci. USA 108, 3047–3052 (2011).
Clarke, G. et al. Minireview: Gut microbiota: the neglected endocrine organ. Mol. Endocrinol. 28, 1221–1238 (2014).
Kennedy, P. J., Cryan, J. F., Dinan, T. G. & Clarke, G. Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology 112, 399–412 (2017).
Sarkar, A. et al. Psychobiotics and the manipulation of bacteria-gut-brain signals. Trends Neurosci. 39, 763–781 (2016).
McEwen, B. S. et al. Mechanisms of stress in the brain. Nat. Neurosci. 18, 1353–1363 (2015).
Murray, E. A. & Wise, S. P. Interactions between orbital prefrontal cortex and amygdala: advanced cognition, learned responses and instinctive behaviors. Curr. Opin. Neurobiol. 20, 212–220 (2010).
Luo, Y. W. et al. Insulin-like growth factor 2 mitigates depressive behavior in a rat model of chronic stress. Neuropharmacology 89, 318–324 (2015).
Willner, P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52, 90–110 (2005).
Kim, K. S. & Han, P. L. Optimization of chronic stress paradigms using anxiety- and depression-like behavioral parameters. J. Neurosci. Res. 83, 497–507 (2006).
Shao, W. H. et al. Combined metabolomics and proteomics analysis of major depression in an animal model: perturbed energy metabolism in the chronic mild stressed rat cerebellum. OMICS 19, 383–392 (2015).
Fulde, M. et al. Neonatal selection by Toll-like receptor 5 influences long-term gut microbiota composition. Nature 560, 489–493 (2018).
Yang, X. et al. Effects of chronic stress on intestinal amino acid pathways. Physiol. Behav. 204, 199–209 (2019).
Ma, W. et al. Chronic paradoxical sleep deprivation-induced depression-like behavior, energy metabolism and microbial changes in rats. Life Sci. 225, 88–97 (2019).
Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569–573 (2013).
Pascale, A. et al. Microbiota and metabolic diseases. Endocrine 61, 357–371 (2018).
Deng, F. L. et al. Metabonomics reveals peripheral and central shortchain fatty acid and amino acid dysfunction in a naturally occurring depressive model of macaques. Neuropsychiatr. Dis. Treat. 15, 1077–1088 (2019).
Skonieczna-Żydecka, K. et al. Faecal short chain fatty acids profile is changed in polish depressive women. Nutrients 10, 1939 (2018).
Keller, J. et al. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Mol. Psychiatry 22, 527–536 (2017).
Farrell, C. et al. DNA methylation differences at the glucocorticoid receptor gene in depression are related to functional alterations in hypothalamic–pituitary–adrenal axis activity and to early life emotional abuse. Psychiatry Res. 265, 341–348 (2018).
Lyte, M. Microbial endocrinology: host-microbiota neuroendocrine interactions influencing brain and behavior. Gut Microbes 5, 381–389 (2014).
Rea, K., Dinan, T. G. & Cryan, J. F. The microbiome: a key regulator of stress and neuroinflammation. Neurobiol. Stress 4, 23–33 (2016).
Bárcena, C. et al. Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice. Nat. Med. 25, 1234–1242 (2019).
Rea, K., Dinan, T. G. & Cryan, J. F. Gut microbiota: a perspective for psychiatrists. Neuropsychobiology 79, 50–62 (2020).
Yano, J. M. et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161, 264–276 (2015).
Louis, P., Hold, G. L. & Flint, H. J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 12, 661–672 (2014).
Evans, J. M., Morris, L. S. & Marchesi, J. R. The gut microbiome: the role of a virtual organ in the endocrinology of the host. J. Endocrinol. 218, R37–R47 (2013).
Frost, G. et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat. Commun. 5, 3611 (2014).
Acknowledgements
This work was supported by the Natural Science Foundation Project of China (81701360), the Chongqing Yuzhong District Science and Technology Commission (20190115), the fund from the Joint International Research Laboratory of Reproduction and Development, Institute of Life Sciences, Chongqing Medical University, Chongqing, China and also supported by the Scientific Research and Innovation Experiment Project of Chongqing Medical University (CXSY201862, CXSY201863).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wu, M., Tian, T., Mao, Q. et al. Associations between disordered gut microbiota and changes of neurotransmitters and short-chain fatty acids in depressed mice. Transl Psychiatry 10, 350 (2020). https://doi.org/10.1038/s41398-020-01038-3
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41398-020-01038-3
- Springer Nature Limited
This article is cited by
-
Non-invasive VOCs detection to monitor the gut microbiota metabolism in-vitro
Scientific Reports (2024)
-
The cancer-immune dialogue in the context of stress
Nature Reviews Immunology (2024)
-
An UHPLC-QE-Orbitrap-MS Method for Accurate Quantification of Short-Chain Fatty Acids in Serum From an Older Chinese Population
Chromatographia (2024)
-
Review of research progress on intestinal microbiota based on metabolism and inflammation for depression
Archives of Microbiology (2024)
-
Microbiota-Gut-Brain Axis in Psychiatry: Focus on Depressive Disorders
Current Epidemiology Reports (2024)